National Action Plan on Antimicrobial Resistance (AMR) 2016-2020 and relevant activities in Japan

Norio Ohmagari1

  • 1AMR Clinical Reference Center, Disease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.

Global Health & Medicine
|December 17, 2020
PubMed

Insights

Antimicrobial resistance (AMR) is a growing global threat. Japan

Area of Science:

  • Public Health
  • Infectious Diseases
  • Pharmacology

Background:

  • Antimicrobial resistance (AMR) poses a significant global health challenge, threatening the sustainability of healthcare.
  • The development of new antimicrobials has stagnated, leading to concerns about future treatment options.
  • The World Health Organization (WHO) has established a Global Action Plan on Antimicrobial Resistance.

Purpose of the Study:

  • To outline Japan's National Action Plan on Antimicrobial Resistance.
  • To detail the goals, strategies, and specific actions within the plan.
  • To highlight Japan's unique addition of international cooperation as a sixth objective.

Main Methods:

  • The Japanese National Action Plan was developed based on the WHO's five strategic objectives.
  • A sixth objective focusing on international cooperation was added.
  • Numerical targets were established as performance indicators for achievement by 2020.

Main Results:

  • Japan established its National Action Plan on Antimicrobial Resistance in April 2016.
  • The plan encompasses six strategic fields, integrating global and national objectives.
  • Specific numerical targets were set to measure progress by 2020.

Conclusions:

  • Japan's comprehensive action plan addresses the critical issue of antimicrobial resistance.
  • The plan's inclusion of measurable targets and international cooperation aims to combat the growing threat.
  • This strategic approach is crucial for safeguarding healthcare sustainability against antimicrobial resistance.

Related Concept Videos